Business NewsMarketWire • Adamis Pharmaceuticals Announces Results and Adjournment of Special Meeting

Adamis Pharmaceuticals Announces Results and Adjournment of Special Meeting

Adamis Pharmaceuticals Announces Results and Adjournment of Special Meeting

SAN DIEGO, CA--(Marketwire - March 1, 2010) -  Adamis Pharmaceuticals Corporation (OTCBB: ADMP) announced today that its stockholders approved the previously announced proposed merger transaction with La Jolla Pharmaceutical Company at a special shareholders meeting held on Friday, February 26, 2010. Based on proxies received and voted at the meeting, holders of approximately 59% of the outstanding shares voted in favor of the merger transaction, and holders of less than 0.5% of the outstanding shares voted against the transaction.

View More : http://www.marketwire.com/mw/release.do?id=1124520&sourceType=3
Releted News by marketwire
Dacha Capital Announces Appointment of CEO of Avalon Rare Metals to Advisory Board
Adamis Pharmaceuticals Announces Results and Adjournment of Special Meeting